MERCK THE FDA AND THE VIOXX RECALL CASE STUDY SUMMARY

0 Comments

In , Merck wanted to prove whether Vioxx can reduce colon polyps. DTC creates knowledge gap between the consumer and the marketer when the consumer cannot properly evaluate the information being received. DTC advertisings offer a lot of information such that would require assistance from professionals to be properly evaluated by the consumer in order to make good choices. Wholeheartedly, any legislation by the U. Vioxx was an anti-inflammatory drug used to treat arthritis and acute pain without the stomach irritation caused by other non-steroidal anti-inflammatory drugs NSAIDs. The COX-2 medication was effective for treatment of arthritis and other pains without users being exposed to stomach damage by naproxen.

A limited time offer! Chat with us Please leave your feedback. Reacting to the withdrawal of Vioxx, Steven Galson, acting director of the FDA’s Center for Drug Evaluation and Research said, “We have been concerned and aware of the potential for cardiovascular effects for the last few years, and this is not a total surprise” However, Merck disagreed with all the reports until its own internal study suggested cardiovascular risks if Vioxx was used for more than 18 months. Prefer to pay in another currency? In , Merck wanted to prove whether Vioxx can reduce colon polyps.

This case obviously calls for more and stricter regulations by strengthening the operations of FDA. It is hard to imagine that decision makers at all levels in Merck would ignore the disturbing information provided by their own VIGOR study.

However, Merck disagreed with all the reports until its own internal study suggested cardiovascular risks if Vioxx was used for more than 18 fra.

Merck, looking for ways to entrench its market leadership threatened by impending loss of patent, relied heavily on Vioxx to capture the painkiller drug market with which it hoped to shore up its profile and revenue. The possibility that the knowledge gap would exist is very high especially among the teh privileged members of the society. Excluding patients with high risk of heart problem, the study gave some patients high doses of Vioxx and precluded them from taking aspirin.

  BU GMS MAMS THESIS

Prefer to pay in another currency? The protagonists of DTC advertising have often argued that the mode has raised the awareness for thw access to important new medications as well as the ability of patients to gda engage their physicians in informed discussions about their prescription drugs.

At introduction stage, both Merck and FDA acted unethically by speeding up the review process. With declining fortune, Merck found DTC irresistible and thhe on it heavily to shore up its market share and to remain competitive.

Buy With PayPal Amount to be paid: The antagonists of DTC advertising however, are of the opinion that the advertising cannot provide enough or detailed information that will enable the consumers to make appropriate drug choices Sullivan, Public health is too important to be viosx the whims of the pharmaceutical industry to manipulate as they have been doing over the years with their unrestrained budgets on DTC.

The drug had been taken by 84 mn people worldwide since its introduction and at the time of its recall 2 mn people were using it.

Case Study: Merck & Company: the Vioxx Recall | Free Essays –

Surprisingly, Merck would ignore the recommendation only to be forced to include a warning label that highlight the fewer stomach problems but to expressly include a warning about possibly more heart attacks and znd Beauchamp et al, Marketing and advertising do not discriminate between segments of the society.

A limited time acse Retrieved May 22,from https: DTC creates knowledge gap between the consumer and the marketer when the consumer cannot properly evaluate the information being received. The belief through trials in Merck was that while Vioxx provides guarantee against stomach damage, there is no increased risk to the heart.

Nor is it a primary information source. Upper Saddle River, NJ: Reczll was the fastest selling drug in Merck’s product portfolio, thanks to the company’s aggressive marketing strategy.

The Recall of Vioxx

The Ethical Considerations Clearly, the objective to regain and maintain leadership position in the pharmaceutical industry was paramount to Merck than getting a safe product to the market. I Case Study Volumes Collection.

  MMU HANDING IN COURSEWORK LATE

merck the fda and the vioxx recall case study summary

Merck Ag Pharmaceutical Industry and E. Congress to ban direct-to-consumer DTC is supported by this author. A pharmaceutical company should have no control over the information that is disclosed about its products because patients rely on the expertise of the physicians to make the best choice for them.

Case Study: Merck & Company: the Vioxx Recall

BECG click on the button below, and select the case from the list of available cases: That is why physicians and researchers should be made to disclose their pecuniary interest in any pharmaceutical company and in its drugs. Case Study Volumes Collection.

merck the fda and the vioxx recall case study summary

Next to this was the approval of Vioxx for marketing to the public by FDA. The purpose of this paper is to make an exposition of issues that the recall case entailed including the ethical issues that were involved, and the propriety of DTC advertising method.

These include the competitiveness of very high magnitude that existed in the pharmaceutical industry in the s and the dilemma that Merck faced as a result of a number of its patents that were due to expire. Want to get a price estimate for your Essay? COX-2 inhibitors are the newest form of nonsteroidal anti-inflammatory drugs NSAIDs and Vioxx, as one of them, was developed to overcome the stomach irritation and gastric bleeding associated with older NSAIDs with COX-1 and Cox-2 inhibitors, which include aspirin, ibuprofen, and naproxen to treat people who are in need of long-term pain relief.

During this period, it was discovered by some researchers that COX-2 inhibitors such as Vioxx would interfere with enzymes that very likely to prevent cardiovascular disease.